Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Harvard Business School
US Department of Justice
Novartis
Deloitte
Merck
AstraZeneca
Accenture
Fish and Richardson
Fuji

Generated: February 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,983,395

« Back to Dashboard

Summary for Patent: 4,983,395
Title: Device for administering an active agent to the skin or mucosa
Abstract:A transdermal drug delivery device comprising a drug formulation-containing reservoir defined by a backing layer and a drug-permeable membrane layer, a peelable inner liner that underlies the reservoir and a portion of the backing/membrane outwardly of the reservoir periphery, an adhesive layer that underlies the inner liner and outwardly extending portions of the membrane/backing layers, and a peelable release liner layer that underlies the adhesive layer with a first permanent heat seal between the backing and the membrane about the perimeter of the reservoir and another concentric peelable (impermanent) heat seal between the membrane and the inner liner positioned underlying and at a radius not less than the first permanent heat seal, the heat seals and peelable barrier layer providing barriers that isolate the drug formulation from the adhesive.
Inventor(s): Chang; Yunik (Toms River, NJ), Patel; Dinesh C. (Murray, UT), Ebert; Charles D. (Salt Lake City, UT)
Assignee: TheraTech Inc. (Salt Lake City, UT)
Application Number:07/326,536
Patent Claim Types:
see list of patent claims
Device; Formulation;

Drugs Protected by US Patent 4,983,395

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 4,983,395

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 154751 ➤ Try a Free Trial
Austria 81023 ➤ Try a Free Trial
Australia 2467788 ➤ Try a Free Trial
Australia 5341690 ➤ Try a Free Trial
Australia 603531 ➤ Try a Free Trial
Australia 631417 ➤ Try a Free Trial
Canada 1302824 ➤ Try a Free Trial
Canada 2053272 ➤ Try a Free Trial
Germany 3875068 ➤ Try a Free Trial
Germany 69030974 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Colorcon
Fuji
AstraZeneca
QuintilesIMS
Harvard Business School
Cantor Fitzgerald
Johnson and Johnson
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot